Choosing the appropriate salvage therapy for B-cell non-Hodgkin lymphoma. Expert Opin Pharmacother 2018 Oct;19(15):1631-1634
Date
09/12/2018
Pubmed ID
30200789DOI
10.1080/14656566.2018.1518430Scopus ID
2-s2.0-85053325343 (requires institutional sign-in at Scopus site)
1 CitationAuthor List
Hashmi H, Hamadani M, Awan FT
Author
Mehdi H. Hamadani MD Professor in the Medicine department at Medical College of Wisconsin